Blood analysis is crucial for early cancer screening and improving patient survival rates. However, developing an effective strategy for early cancer detection using high-throughput blood analysis is still challenging. Herein, a novel automatic super-hydrophobic platform is developed together with a deep learning (DL)-based label-free serum and surface-enhanced Raman scattering (SERS), along with an automatic high-throughput Raman spectrometer to build an effective point-of-care diagnosis system. A total of 695 high-quality serum SERS spectra are obtained from 203 healthy volunteers, 77 leukemia M5, 94 hepatitis B virus, and 321 breast cancer patients. Serum SERS signals from the normal (n = 183) and patient (n = 443) groups are used to assess the DL model, which classify them with a maximum accuracy of 100%. Furthermore, when SERS is combined with DL, it exhibits excellent diagnostic accuracy (98.6%) for the external held-out test set, indicating that this method can be used to develop a high throughput, rapid, and label-free tool for screening diseases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.